| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 01/31/2002 | WO2001014328A3 Substituted ureas as cell adhesion inhibitors |
| 01/31/2002 | WO2000034261A3 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group |
| 01/31/2002 | US20020013481 Use of flavones flavanones and flavonoids for protecting ascorbic acid and/or ascorbyl compounds from oxidation |
| 01/31/2002 | US20020013479 Process and catalyst for the production of gamma-butyrolactones |
| 01/31/2002 | US20020013475 Catalyst for unsaturated carbonyl compounds |
| 01/31/2002 | US20020013360 Protease inhibitors |
| 01/31/2002 | US20020013357 Valdecoxib compositions |
| 01/31/2002 | US20020013352 Novel substituted diamine derivatives useful as motilin antagonists |
| 01/31/2002 | US20020012683 Cosmetic composition comprising at least one ingredient chosen from compounds of formula (1) and salts thereof, use thereof as colouring agent, and novel compounds of formulae (IIa), (IIIa), (IVa), (Va), and (VIa), and salts thereof |
| 01/31/2002 | CA2417000A1 Hyperpolarizable organic chromophores |
| 01/31/2002 | CA2416447A1 Novel compounds and their use as glycine transport inhibitors |
| 01/30/2002 | EP1176139A1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors |
| 01/30/2002 | EP1176134A1 Ligands of nuclear receptors ppar's |
| 01/30/2002 | EP1175500A1 Method for the selective esterification of polyoles |
| 01/30/2002 | EP1175214A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 01/30/2002 | EP0941220B1 A process for recovery of ascorbic acid |
| 01/30/2002 | CN1333770A Novel dicyclic compound |
| 01/30/2002 | CN1333769A Thiourea inhibitors of herps viruses |
| 01/30/2002 | CN1333764A Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 01/30/2002 | CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 01/30/2002 | CN1078586C Phenylalkanamide derivatives and agrohor-ticultural bactericides |
| 01/29/2002 | US6342633 O-benzyl oxime ether derivatives and their use as pesticides |
| 01/29/2002 | US6342614 Isomerization of gamma, delta-epoxyalkenes or gamma, delta-epoxycycloalkenes to 2,5-dihydrofurans using catalytic system which comprises onium iodide and lewis acid |
| 01/29/2002 | US6342532 Antiarthritic, hypotensive agents for urogenital and glandular disorders; calcium channels modulators |
| 01/29/2002 | US6342521 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 01/29/2002 | US6342513 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 01/29/2002 | US6342511 Racemic, enantiomorphs and diasteriomorphs |
| 01/29/2002 | US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/29/2002 | US6342379 Detection of transmembrane potentials by optical methods |
| 01/24/2002 | WO2002006430A1 Marine oils with reduced levels of contaminants |
| 01/24/2002 | WO2002006276A1 Beta3 adrenergic agonists |
| 01/24/2002 | WO2002006267A2 Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a |
| 01/24/2002 | WO2002006264A1 Lipid-rich plaque inhibitors |
| 01/24/2002 | WO2002006263A1 Process for the preparation of a benzofuran derivative |
| 01/24/2002 | WO2002006262A1 Process for producing hydroxylactone |
| 01/24/2002 | WO2002006261A1 Tocotrienolquinone cyclisation product with an anti-hypercholesterol effect |
| 01/24/2002 | WO2002006189A2 Aniline derivatives |
| 01/24/2002 | WO2002005848A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/24/2002 | WO2002005834A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 01/24/2002 | WO2002005815A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | WO2001077096A3 Preparation of natural thioacetates and derivatives |
| 01/24/2002 | US20020010346 Process for producing trimellitic anhydride |
| 01/24/2002 | US20020010286 Multifunctional cyanate ester and epoxy blends |
| 01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |
| 01/24/2002 | US20020010204 Use as pesticides. |
| 01/24/2002 | US20020010185 Anticarcinogenic agents |
| 01/24/2002 | US20020010178 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effect |
| 01/24/2002 | US20020009650 High electroconductivity |
| 01/24/2002 | DE10034233A1 Tocotrienolchinon-Cyclisierungsprodukte Tocotrienolquinone cyclization products |
| 01/24/2002 | CA2429008A1 Lipid-rich plaque regressing agents |
| 01/24/2002 | CA2415331A1 Beta3 adrenergic agonists |
| 01/24/2002 | CA2415285A1 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds |
| 01/24/2002 | CA2414780A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 01/24/2002 | CA2414674A1 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173431A2 Method for the preparation of citalopram |
| 01/23/2002 | EP1173430A1 Enantiomers of mercapto lactones and processes for their synthesis |
| 01/23/2002 | EP1173420A2 Heterocyclic compounds having antitumor activity |
| 01/23/2002 | EP1173414A1 N-protected amines and their use as prodrugs |
| 01/23/2002 | EP1173411A1 Polyaldimines of oligomeric aminobenzoic acid derivatives, and their use for preparation of moisture-curable, storage-stable, one-part polyreas |
| 01/23/2002 | EP1173400A1 Process for the preparation of 3,4-dihydroxybutanoic acid and derivatives thereof from substituted pentose sugars |
| 01/23/2002 | EP1173265A1 Sonic impinging jet crystallization apparatus and process |
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP0904269B1 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 01/23/2002 | EP0833826B1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 01/23/2002 | CN1332780A Process for recovery of low molecular weight phenols, furfural, furfuryl alcohol and/or cellulose or cellulose-rich residues |
| 01/23/2002 | CN1332735A Process to afford gamma butyrolactone and tetrahydrofuran |
| 01/23/2002 | CN1332725A Thiourea inhibitors of herpes viruses |
| 01/23/2002 | CN1332722A 2-substituted Retoamides |
| 01/23/2002 | CN1078204C Amino acid amide derivative and fungicidal use and production process thereof |
| 01/22/2002 | US6340764 Reference compound for use in the analysis of levosimendan batches |
| 01/22/2002 | US6340709 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 01/22/2002 | CA2064872C Aryloxymethylcarbonochloridate ester intermediates, their production and use in synthesizing prodrugs and their use therefor |
| 01/20/2002 | CA2358356A1 Pharmaceutical composition containing citalopram |
| 01/17/2002 | WO2002004435A1 Method for the preparation of citalopram |
| 01/17/2002 | WO2002004412A2 Tyrosine derivatives as phosphatase inhibitors |
| 01/17/2002 | WO2002004407A2 7-substituted tetracycline compounds |
| 01/17/2002 | WO2002004404A2 7,8 and 9-substituted tetracycline compounds |
| 01/17/2002 | WO2002003995A2 Treatment of male sexual dysfunction |
| 01/17/2002 | WO2001062726A3 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 01/17/2002 | WO2001046125A3 Cd45 inhibitors |
| 01/17/2002 | WO2001042211A3 Detection of transmembrane potentials by optical methods |
| 01/17/2002 | US20020007060 Enzyme inhibitors; connective tissue cells; antiarthritic agents; anticarcinogenic agents |
| 01/17/2002 | US20020006960 Neuraminidase inhibitors |
| 01/17/2002 | US20020006957 Method for the synthesis of compounds of formula I and their uses thereof |
| 01/17/2002 | US20020006951 Solid-state form of celecoxib having enhanced bioavailability |
| 01/17/2002 | US20020006922 Metalloprotease inhibitors |
| 01/17/2002 | DE10032242A1 Medicinal use of galiella lactone as specific interleukin-6 signal induction inhibitor e.g. in treatment of fibrotic, cerebrovascular or neurodegenerative disease, pain, inflammation or tumors |
| 01/17/2002 | DE10032132A1 Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung A dermal therapeutic system containing NSAIDs with selective COX-2 inhibition |
| 01/17/2002 | CA2415086A1 7,8 and 9-substituted tetracycline compounds |
| 01/17/2002 | CA2414112A1 Treatment of male sexual dysfunction |
| 01/17/2002 | CA2383963A1 Method for the preparation of citalopram |
| 01/16/2002 | EP1172432A1 Perfume precursor compositions and method for expressing perfume components |
| 01/16/2002 | EP1172369A1 Synthesis of 2-deoxy-2-fluoro-arabinose derivates |
| 01/16/2002 | EP1172104A1 Seam soft capsule preparations containing dihydrobenzofuran derivative |
| 01/16/2002 | EP1171665A1 Process for the production of furfural from lignosulphonate waste liquor |
| 01/16/2002 | EP1171433A1 Preparation of norlabdane oxide |
| 01/16/2002 | EP1171422A1 Mmp inhibitor |
| 01/16/2002 | EP1171414A1 Compounds, their preparation and use |
| 01/16/2002 | EP1171237A1 Vanadium phosphorus oxide catalyst having a thermally conductive support |